LABEL Act
United States119th CongressHR-5969House of Representatives
Updated: Nov 7, 2025
Summary
This proposed legislation, titled the "LABEL Act," seeks to amend the Federal Food, Drug, and Cosmetic Act by establishing new labeling requirements for abortion-inducing drugs. Under this bill, such drugs would be considered misbranded unless their labels clearly identify both the name and address of the dispenser and the name of the prescriber . The bill defines an "abortion-inducing drug" as one intended or used to kill an unborn child or terminate a pregnancy, specifically excluding drugs used for removing a dead unborn child or treating an ectopic pregnancy. Furthermore, it prohibits states from implementing or enforcing labeling requirements that are less stringent than these federal standards, aiming to ensure a uniform approach to tracking these medications.
Bill texts
All available records shown.
Timeline
Latest companion bill action
S-3065: LABEL ActRead twice and referred to the Committee on Agriculture, Nutrition, and Forestry.
Referred to the House Committee on Energy and Commerce.
House of Representatives
Introduced in House
All available records shown.